<?xml version="1.0" encoding="UTF-8"?>
<p id="par0190">Drugs identified with high likelihood for antiviral effects due to CAD properties mainly belong to macrocyclic antibacterials, antimalarials, antihistaminics, antivirals and antiparasitic drugs. Since most, except antihistaminics, have non-human targets, they are among the drugs most acceptable for repurposing since their primary pharmacological activity will likely not pose a safety issue. Eight out of 26 identified drugs have already shown effectiveness against either SARS-CoV, SARS-CoV-2 or MERS viruses or two or all of them, adding support to the potential value of this antiviral strategy. These eight drugs are: promethazine, amodiaquine, chloroquine, mefloquine, tilorone, hydroxychloroquine, arbidol (umifenovir) and nelfinavir [
 <xref rid="bib0115" ref-type="bibr">23</xref>] (
 <ext-link ext-link-type="uri" xlink:href="https://drugvirus.info/" id="intr0030" xmlns:xlink="http://www.w3.org/1999/xlink">https://drugvirus.info/</ext-link>).
</p>
